Home » In Focus » Protecting Pregnant Women with HIV and Their Infants Against Pneumococcus

Protecting Pregnant Women with HIV and Their Infants Against Pneumococcus

April 29, 2021

Pneumococcus is a significant danger to pregnant women with HIV and their infants. PCV-10 and PPV-23 are 2 vaccines that help protect against invasive disease like pneumococcus. New research has compared the safety and immunogenicity of PCV-10 and PPV-23 administered in pregnancy.

In a new article published in the Lancet, Westat’s Lauren Laimon, M.S., Lassallete Newton, and coauthors note that PCV-10 and PPV-23 were equally safe and immunogenic in pregnant women with HIV and conferred similar levels of seroprotection to their infants. Learn more: Safety, Immunogenicity, and Transplacental Antibody Transport of Conjugated and Polysaccharide Pneumococcal Vaccines Administered to Pregnant Women With HIV: A Multicentre Randomized Controlled Trial.

More News

  • Westat CLS—Showcasing CRO Services to Commercial Clients

    Westat CLS—Showcasing CRO Services to Commercial Clients

  • What Pneumonia Vaccine Prompts the Best Immunity Response in Infants Whose Mothers Have HIV?

    What Pneumonia Vaccine Prompts the Best Immunity Response in Infants Whose Mothers Have HIV?

  • First Next-Generation Freeze-Dried Plasma (FDP) Product Found to Be as Safe and Potent as Fresh Frozen Plasma (FFP)

    First Next-Generation Freeze-Dried Plasma (FDP) Product Found to Be as Safe and Potent as Fresh Frozen Plasma (FFP)